AAB
LLY icon

ABN AMRO Bank’s Eli Lilly LLY Stock Holding History

ABN AMRO Bank’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199M Sell
164,869
-74,831
-31% -$76.5M 2.57% 9
2026
Q1 		$221M Sell
239,700
-9,349
-4% -$9.48M 2.39% 10
2025
Q4 		$267M Buy
249,049
+43,004
+21% +$41.1M 2.51% 8
2025
Q3 		$157M Buy
206,045
+5,146
+3% +$3.83M 1.54% 24
2025
Q2 		$157M Buy
200,899
+1,796
+0.9% +$1.4M 2.05% 20
2025
Q1 		$164M Buy
199,103
+190,552
+2,228% +$159M 2.27% 22
2024
Q4 		$6.53M Buy
8,551
+4,002
+88% +$3.31M 0.09% 77
2024
Q3 		$4M Buy
4,549
+3,791
+500% +$3.41M 0.05% 90
2024
Q2 		$694K Sell
758
-180
-19% -$144K 0.01% 125
2024
Q1 		$731K Sell
938
-655
-41% -$466K 0.01% 122
2023
Q4 		$934K Sell
1,593
-700
-31% -$409K 0.02% 114
2023
Q3 		$1.23M Sell
2,293
-230
-9% -$119K 0.02% 105
2023
Q2 		$1.19M Sell
2,523
-97
-4% -$40.7K 0.02% 99
2023
Q1 		$900K Buy
+2,620
New +$884K 0.02% 103

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ABN AMRO Bank's LLY Position: Q2 2026 in Review

ABN AMRO Bank reduced its Eli Lilly (LLY) stake by 31% in Q2 2026, selling an estimated $76.5M and leaving 164,869 shares worth $199M. The position accounts for 2.57% of the portfolio, ranked #9.

ABN AMRO Bank first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. The position peaked at $267M in Q4 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ABN AMRO Bank held 164,869 shares of Eli Lilly worth $199M as of Q2 2026.
  • ABN AMRO Bank sold 74,831 Eli Lilly shares in Q2 2026, an estimated $76.5M.
  • Eli Lilly made up 2.57% of ABN AMRO Bank's portfolio in Q2 2026, its #9 holding.
  • ABN AMRO Bank first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Bank's Eli Lilly position peaked at $267M in Q4 2025.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.